Businessman and Chicago Resident Jeff Aronin

Paragon Biosciences is a biomedical company transforming the lives of people through building and growing top biotechnology companies. Leading this remarkable company is an entrepreneur, innovator, and mentor by the name of Jeff Aronin (https://thenewsversion.com/2018/02/jeff-aronin/).

Jeff Aronin embarked on his healthcare and technology journey after graduating with a bachelor’s’ degree from Northern Illinois University and an MBA from DePaul University. He began his career in healthcare before making the major move of becoming the founder and CEO of Ovation Pharmaceuticals in 2000. Jeff felt like he could do more for patients especially with those who had uncommon or neglected illnesses. This pharmaceutical startup eventually went on to be purchased for $900 million dollars. Jeff stayed on as CEO leading the company to much success.

Early in his career, Jeff Aronin was always passionate about healthcare and wanting to improve the lives of people through medicine and biotechnology. Jeff combined his many years of business experience, brand marketing and finance strategies, leadership mindset and passion for healthcare and technology into his next company. After Jeff’s first company, he launched Paragon Biosciences.

Paragon Biosciences is a Chicago based incubator and investment firm that builds companies in the biotechnology field. The biotechnology company focuses on understanding the patient’s needs, the science behind the disease and creating companies to address the needs of those who have unmet medical needs. Paragon’s strategy consists of three steps: learning the disease, understanding the science and doing the guesswork. The result is solving the needs of unmet medical issues with an approval form of medicine.

There are four companies under the Paragon Biosciences portfolio: Castle Creek, Harmony Biosciences, Decade and Precision BP. Castle Creek Pharmaceuticals is a privately held pharmaceutical company developing therapies for rare and dermatologic conditions. Harmony Biosciences focuses on creating innovative drugs to meet the needs of sleep patients. Decade focuses on Alzheimer’s disease research. Precision BP focuses on developing treatments for genetic oncology diseases.

Jeff Aronin continues to be on the forefront of medicine and biotechnology with his innovative companies. Jeff and Paragon Biosciences continue to make a profound impact in aiding people with unmet medical illnesses.

Leave a Reply

Your email address will not be published. Required fields are marked *